Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer

Małgorzata Wachowska,Angelika Muchowicz,Małgorzata Firczuk,Magdalena Gabrysiak,Magdalena Winiarska,Małgorzata Wańczyk,Kamil Bojarczuk,Jakub Golab

DOI: https://doi.org/10.3390/molecules16054140

IF: 4.6

2011-05-19

Molecules

Abstract:Aminolevulinic acid (ALA) is an endogenous metabolite normally formed in the mitochondria from succinyl-CoA and glycine. Conjugation of eight ALA molecules yields protoporphyrin IX (PpIX) and finally leads to formation of heme. Conversion of PpIX to its downstream substrates requires the activity of a rate-limiting enzyme ferrochelatase. When ALA is administered externally the abundantly produced PpIX cannot be quickly converted to its final product - heme by ferrochelatase and therefore accumulates within cells. Since PpIX is a potent photosensitizer this metabolic pathway can be exploited in photodynamic therapy (PDT). This is an already approved therapeutic strategy making ALA one of the most successful prodrugs used in cancer treatment.

chemistry, multidisciplinary,biochemistry & molecular biology